v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current assets:      
Cash and cash equivalents $ 37,648,797 $ 28,417,310 $ 800,728
Short-term investments 10,067,886  
Tax incentive and other receivables 933,250  
Prepaid expenses 636,015 834,479
Total current assets 49,285,948 29,251,789 800,728
Total assets 49,285,948 29,251,789 800,728
Current liabilities:      
Accounts payable 3,432,161 260,613
Accrued expenses and other current liabilities 6,261,309 2,293,643 856,144
Total current liabilities 9,693,470 2,554,256 856,144
Total liabilities 12,686,523 5,496,524 856,144
Commitments and contingencies (Note 4)
Redeemable convertible preferred stock, $0.0001 par value, 13,661,416 shares authorized, issued, and outstanding at December 31, 2023   5,466,925
Stockholders’ equity (deficit):      
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, and no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.0001 par value, 300,000,000 shares authorized; 32,198,214 and 27,198,214 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 4,720 2,720 76
Related party notes receivable (4,124,274) (4,065,096)
Additional paid-in capital 85,734,267 66,630,765 16,203,254
Accumulated deficit (45,015,288) (38,813,124) (21,725,671)
Total stockholders’ equity 36,599,425 23,755,265 (5,522,341)
Total liabilities and stockholders’ equity 49,285,948 29,251,789 800,728
Related Parties      
Current liabilities:      
Notes payable – related parties $ 2,993,053 $ 2,942,268